Innovating targeting

Philogen is a Swiss-Italian biotechnology company, founded in 1996 and listed on the Italian Stock Exchange, with a mission to innovate the treatment of cancer and other serious conditions

Innovating targeting

Philogen is a Swiss-Italian biotechnology company, founded in 1996 and listed on the Italian Stock Exchange, with a mission to innovate the treatment of cancer and other serious conditions

 

Philogen to attend the ASCO congress in Chicago on May 30-31, June 1-3, 2024

Prof. Dr. Axel Hauschild, on behalf of Philogen, is giving a presentation about the Phase III PIVOTAL study on May 31st, entitled “Phase 3 study (PIVOTAL) of...

Philochem to attend the 72nd ASMS Conference on Mass Spectrometry and Allied Topics in Anaheim on June 2-6, 2024

Dr. Ettore Gilardoni (Head of Mass Spectrometry) will attend the 72nd ASMS conference in Anaheim (2-6 June 2024) and present a poster entitled: “Mass Spectrometry...

Philogen to attend the SNMMI Annual Meeting in Toronto on June 8-11, 2024

Dr. Andrea Galbiati is giving a presentation about Philochem’s FAP ligand platform on June 9th, entitled “Development of Multivalent OncoFAP Derivatives for the...

Philogen to attend the Chemical Biology conference at Novo Nordisk on June 8-9, 2024.

Philogen to attend the Goldman Sachs 45th Annual Global Healthcare Conference in Miami on June 12, 2024.

The conference provides an opportunity for investors to learn about Philogen's progress and to meet CEO/CSO Prof. Dario Neri through a series of one-on-one meetings....

Philochem to attend as Lecturer to the Summer School in Pharmaceutical Analysis 2024 in Rimini on September 18-20, 2024

Dr. Ettore Gilardoni (Head of Mass Spectrometry) will participate as Lecturer to the Summer School in Pharmaceutical Analysis 2024 in Rimini with a presentation on...

The Board of Directors approves the Net Financial Position for the First Quarter of 2024

more details

Il Consiglio di Amministrazione approva la Posizione Finanziaria Netta relativa al Primo Trimestre 2024

more details

L’Assemblea degli Azionisti di Philogen S.p.A. si è riunita in data odierna, in sede ordinaria e straordinaria

more details

Errata Corrige – Parziale Rettifica del Comunicato Stampa del 5 Aprile 2024

more details

OUR SCIENCES

Learn about our strategy

PIPELINE

Learn more about our pipeline

WORK WITH US

Look at open positions